Hookipa Biotech Gmbh
Clinical trials sponsored by Hookipa Biotech Gmbh, explained in plain language.
-
Experimental vaccine therapy shows promise against HPV-Linked cancers
Disease control CompletedThis study tested two experimental vaccines (HB-201 and HB-202) in 198 people with HPV 16-positive cancers. The goal was to find the safest dose and see if the vaccines could shrink tumors. The approach uses the body's immune system to fight cancer cells, but ongoing treatment or…
Phase: PHASE1, PHASE2 • Sponsor: Hookipa Biotech GmbH • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Real-world data on throat cancer treatments could shape future studies
Knowledge-focused CompletedThis study looked at 662 people with HPV-positive throat cancer that had spread or come back. Researchers checked how patients were treated with pembrolizumab or nivolumab (with or without chemo) in real-world clinics. The goal was to gather information to help design better futu…
Sponsor: Hookipa Biotech GmbH • Aim: Knowledge-focused
Last updated May 13, 2026 15:59 UTC